Adma Biologics, Inc. balance sheet

At the end of fiscal 2025, Adma Biologics, Inc. had total assets of $624m, total liabilities of $147m and shareholders' equity of $477m. It held $87.6m in cash against $72.1m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Adma Biologics, Inc.: balance sheet, annual
Fiscal year	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	0	13	26	17	10	10	43	27	27	56	51	87	51	103	88	136
Receivables	0	0	0	0	1	1	4	1	3	13	29	16	27	50	158	138
Inventory	1	1	2	2	3	5	13	19	53	82	125	163	173	170	206	239
Total current assets	1	14	31	24	21	22	62	45	86	154	209	270	257	331	467	528
Goodwill	—	—	—	—	—	0	4	4	4	4	4	4	4	4	4	4
Total assets	3	16	32	27	24	24	108	89	127	208	276	348	329	489	624	684
Accounts payable	1	1	3	2	2	3	6	6	9	11	12	13	16	20	23	32
Deferred revenue (current)	—	—	—	—	—	0	0	0	0	0	0	0	0	0	—	—
Total current liabilities	2	2	4	4	4	11	9	10	14	20	30	39	50	56	70	76
Short-term debt	—	—	—	—	—	—	—	—	—	—	—	—	—	0	3	4
Long-term debt	—	4	5	15	14	2	3	3	0	93	95	143	131	72	69	193
Total debt	0	4	5	15	14	18	25	30	73	93	95	0	0	72	72	198
Total liabilities	3	6	10	21	23	28	68	69	101	119	135	196	194	140	147	276
Shareholders' equity	0	9	22	6	1	−4	40	20	26	88	141	152	135	349	477	408
Shares outstanding	20m	—	28m	37m	43m	52m	37m	46m	59m	105m	—	222m	226m	237m	238m	225m

US$ millions unless shown otherwise. Fiscal quarters.

Adma Biologics, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	50	50	99	110	138	158	136	138
Inventory	172	170	172	191	197	206	222	239
Total current assets	318	331	352	400	403	467	511	528
Goodwill	4	4	4	4	4	4	4	4
Total assets	391	489	511	558	569	624	665	684
Accounts payable	16	20	21	30	24	23	21	32
Deferred revenue (current)	0	0	0	0	—	—	—	—
Total current liabilities	45	56	53	75	56	70	74	76
Short-term debt	—	0	—	—	2	3	3	4
Long-term debt	101	72	73	73	70	69	194	193
Total debt	101	72	73	73	72	72	197	197
Total liabilities	159	140	137	160	138	147	275	276
Shareholders' equity	232	349	373	398	431	477	390	408
Shares outstanding	236m	237m	239m	239m	238m	238m	232m	225m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ADMA vs HCM ADMA vs KRYS ADMA vs ARQT

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Adma Biologics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Adma Biologics, Inc.